搜索结果: 1-8 共查到“2019-nCoV”相关记录8条 . 查询时间(0.048 秒)
荧光免疫层析法检测全血2019-nCoV IgM 和IgG 抗体在新型冠状病毒肺炎诊断中的应用
荧光免疫层析法 新型冠状病毒 2019-nCoV COVID-19 免疫球蛋白M 免疫球蛋白G
2021/3/17
探究荧光免疫层析法检测IgM 和IgG 抗体在诊断新型冠状病毒肺炎（COVID-19）患者中的应用价值。 方法 选取2020 年1~2 月在隔离病区收治观察的28 例留观患者作为观察组，均是首次新型冠状病毒（2019-nCoV）咽 拭子核酸检测阳性而第二次以后连续两次核酸检测为阴性的患者，将同期发热门诊排除COVID-19 的30 例发热患者作 为对照组，采用荧光免疫层析法检测所有研究对象的201...
通过胶体金法和化学发光法检测血清中的新型冠状病毒（2019-nCoV）特异性总抗体，对两种方法的敏感度和特异度等进行初步的比较和评价。方法 本研究采用回顾性研究方法，收集2020 年2 月5 日~ 25 日在襄阳市第一人民医院就诊的门诊和住院患者病例119 例，根据《新型冠状病毒肺炎诊疗方案（试行第六版）》标准分为确诊病例组28 例，疑似病例组53 例，健康对照组38 例。采用胶体金试剂盒和全自动...
Inhibition of SARS-CoV-2 (Previously 2019-nCoV) Infection by a Highly Potent Pan-Coronavirus Fusion Inhibitor Targeting Its Spike Protein That Harbors a High Capacity to Mediate Membrane Fusion
Inhibition SARS-CoV-2 Pan-Coronavirus Fusion Inhibitor Targeting High Capacity Mediate Membrane Fusion
2020/6/12
The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection in Wuhan, China has posed a serious threat to global public health. To develop specific anti-coronavirus therapeuti...
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
2019-nCoV Wuhan pneumonia epidemiology swabs intestine
2020/6/12
In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through respiratory tr...
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Fusion mechanism 2019-nCoV inhibitors targeting HR1 domain spike protein
2020/6/12
Very recently, a novel coronavirus, 2019-nCoV, emerged in Wuhan, China and then quickly spread worldwide, resulting in >17,388 confirmed cases and 361 deaths as of 3 February 2020, thus calling for th...
Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases
Clinical Features Treatment 2019-nCov Pneumonia Patients Wuhan
2020/6/12
Till January 20, 2020, the 2019-new coronavirus (2019-nCoV) has caused more than one hundred cases in Wuhan (WMHC 2020). During a retrospective study of recent pneumonia patients in our department, we...
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Remdesivir chloroquine effectively inhibit novel coronavirus (2019-nCoV) vitro
2020/6/12
In December 2019, a novel pneumonia caused by a previously unknown pathogen emerged in Wuhan, a city of 11 million people in central China. The initial cases were linked to exposures in a seafood mark...
